Key points are not available for this paper at this time.
Since Monro published his observations on the nature of the contents of the intracranial space in 1783 there has been investigation of the unique relationship between the contents of the skull and the intracranial pressure (ICP). This is particularly true following traumatic brain injury (TBI), where it is clear that elevated ICP due to the underlying pathological processes is associated with a poorer clinical outcome. Consequently, there is considerable interest in monitoring and manipulating ICP In patients with TBI. The two techniques most commonly used in clinical practice to monitor ICP are via an intraventricular or intraparenchymal catheter with a microtransducer system. Both of these techniques are invasive and are thus associated with complications such as haemorrhage and infection. For this reason, significant research effort has been directed towards development of a non-invasive method to measure ICP. These include imaging based studies using computed tomography (CT) and magnetic resonance imaging (MRI), transcranial Doppler sonography (TCD), near-infrared spectroscopy (NIRS), tympanic membrane displacement (TMD), visual-evoked potentials (VEPs), measurements of optic nerve sheath diameter (ONSD) and other measurements of the optic nerve, retina, pupil and ophthalmic artery. The principle aims of ICP monitoring in TBI are to allow early detection of secondary haemorrhage or ischaemic processes and to guide therapies that limit intracranial hypertension and optimise cerebral perfusion. However, information from the ICP value and the ICP waveform can also be used to estimate intracranial compliance, assess cerebrovascular pressure reactivity and attempt to forecast future episodes of intracranial hypertension.
Hawthorne et al. (Wed,) studied this question.